Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Aug 11, 2025
Date Accepted: Mar 10, 2026

The final, peer-reviewed published version of this preprint can be found here:

Overcoming the HIV Pre-Exposure Prophylaxis Uptake Barrier With A Health Action Process Approach and Conditional Economic Incentives Among Men Who Have Sex With Men in 3 Chinese Cities: Protocol for a Randomized Controlled Trial

Lin H, Ni M, Chang C, Sun F, Li J, Galárraga O, Mo PKH, Cao W

Overcoming the HIV Pre-Exposure Prophylaxis Uptake Barrier With A Health Action Process Approach and Conditional Economic Incentives Among Men Who Have Sex With Men in 3 Chinese Cities: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2026;15:e82123

DOI: 10.2196/82123

PMID: 42008629

Overcoming the HIV Pre-exposure Prophylaxis Uptake Barrier with Health Action Process Approach and Conditional Economic Incentives among Men Who Have Sex with Men in three Chinese cities: Protocol for a Randomized Controlled Trial

  • Hao Lin; 
  • Mojun Ni; 
  • Chun Chang; 
  • Feng Sun; 
  • Jinghua Li; 
  • Omar Galárraga; 
  • Phoenix Kit-Han Mo; 
  • Wangnan Cao

ABSTRACT

Background:

Despite high pre-exposure prophylaxis (PrEP) awareness and willingness among Chinese men who have sex with men (MSM), actual uptake remains critically low. This intention-behavior gap significantly hinders Human Immunodeficiency Virus (HIV) prevention efforts.

Objective:

This randomized controlled trial evaluates the effectiveness of Health Action Process Approach (HAPA) -driven interventions to enhance PrEP initiation and adherence in this high-risk population.

Methods:

High-risk HIV-negative MSM naive to PrEP will be recruited via community-based organizations. Participants will undergo individual randomization to three arms: (1) HAPA-based behavioral intervention featuring tailored WeChat messages and two structured motivational interviews targeting stage-specific barriers; (2) Combined HAPA intervention with group-based conditional economic incentives (GCEI) linked to peer group initiation rates, incorporating facilitated offline group activities; or (3) Standard care control. The physician-prescribed PrEP initiation rate at three months serves as primary outcome. Secondary outcomes include PrEP adherence, HIV risk perception, PrEP-related stigma, and intervention acceptability. Analysis will follow intention-to-treat principles using mixed-effects models.

Results:

.

Conclusions:

This study rigorously tests a novel intervention integrating the HAPA–targeting distinct motivational and volitional phases of PrEP use–with a GCEI model leveraging peer influence. By addressing both individual cognitive-behavioral barriers and financial disincentives within a supportive group context, this approach offers a potentially scalable strategy to bridge the PrEP uptake gap in China. Findings will provide critical evidence on the added value of combining theory-driven behavioral techniques with peer-group economic incentives for HIV prevention. Clinical Trial: This study was registered at ClinicalTrials.gov (NCT06931106).


 Citation

Please cite as:

Lin H, Ni M, Chang C, Sun F, Li J, Galárraga O, Mo PKH, Cao W

Overcoming the HIV Pre-Exposure Prophylaxis Uptake Barrier With A Health Action Process Approach and Conditional Economic Incentives Among Men Who Have Sex With Men in 3 Chinese Cities: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2026;15:e82123

DOI: 10.2196/82123

PMID: 42008629

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.